The pros and cons of a 5th jab for health workers, whether we have reached the end of the road with mRNA-based vaccines, cutting through the subvariant hype, new vaccines on the horizon, and the 2023 forecast - does ATAGI need a rethink?
Expert/s: Dr Gary Grohmann